Reportlinker Adds Disease and Therapy Review: Kidney Transplant
NEW YORK, April 21, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Disease and Therapy Review: Kidney Transplant
http://www.reportlinker.com/p0191991/Disease-and-Therapy-Review--Kidney-Transplant.html
The Kidney Transplant Disease and Therapy Review provides procedure rates and prevalence numbers and percentages for major countries worldwide. Disease processes which can seriously damage kidneys are included, with discussion of diagnosis and prognosis of kidney disease and transplant. Immunosuppressant treatment options are discussed, with dosing and treatment costs provided. Market size estimates and annual sales of leading therapies are also provided.
Table of contents
Overview
General description of the kidney
Conditions leading to kidney transplant
incidence and prevalence
Procedure Rates (US, Canada, Argentina, Brazil, Chile, Colombia, Mexico, UK, France, Germany, Greece, Italy, Poland, Russia, Spain, Sweden, Turkey, China, India, Iran, Japan, Korea, Philippines, Saudi Arabia, Thailand, South Africa, Australia, Worldwide)
Prevalence Table (US, Canada, Argentina, Brazil, Chile, Colombia, Mexico, UK, France, Germany, Greece, Italy, Poland, Russia, Spain, Sweden, Turkey, Hong Kong, Korea, Thailand, Australia, Worldwide)
diagnosis and prognosis
Factors contributing to transplant decisions
Patient prognosis
treatment
General description of procedure
Medical treatment
dosing and treatment costs
Overview of transplant costs
Dosing for commonly prescribed drugs
Costs for commonly prescribed drugs
market size
Overall market size
Sales information for key pharmaceuticals
comments
references/resources
To order this report:
: Disease and Therapy Review: Kidney Transplant
Check our Company Profile, SWOT and Revenue Analysis!
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article